CoChat

Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts

Open access
Ntai, Ioanna, LeDuc, Richard D., Fellers, Ryan T., Erdmann-Gilmore, Petra, Davies, Sherri R., Rumsey, Jeanne, Early, Bryan P., Thomas, Paul M., Li, Shunqiang, Compton, Philip D., Ellis, Matthew J.C., Ruggles, Kelly V., Fenyö, David, Boja, Emily S., Rodriguez, Henry, Townsend, R. Reid, Kelleher, Neil L. · 2016 · Molecular & Cellular Proteomics
Cited by 85

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Bottom-up proteomics relies on the use of proteases and is the method of choice for identifying thousands of protein groups in complex samples. Top-down proteomics has been shown to be robust for direct analysis of small proteins and offers a solution to the "peptide-to-protein" inference problem inherent with bottom-up approaches. Here, we describe the first large-scale integration of genomic, bottom-up and top-down proteomic data for the comparative analysis of patient-derived mouse xenograft models of basal and luminal B human breast cancer, WHIM2 and WHIM16, respectively. Using these well-characterized xenograft models established by the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium, we compared and contrasted the performance of bottom-up and top-down proteomics to detect cancer-specific aberrations at the peptide and proteoform levels and to measure differential expression of proteins and proteoforms. Bottom-up proteomic analysis of the tumor xenografts detected almost 10 times as many coding nucleotide polymorphisms and peptides resulting from novel splice junctions than top-down. For proteins in the range of 0-30 kDa, where quantitation was performed using both approaches, bottom-up proteomics quantified 3,519 protein groups from 49,185 peptides, while top-down proteomics quantified 982 proteoforms mapping to 358 proteins. Examples of both concordant and discordant quantitation were found in a ∼60:40 ratio, providing a unique opportunity for top-down to fill in missing information. The two techniques showed complementary performance, with bottom-up yielding eight times more identifications of 0-30 kDa proteins in xenograft proteomes, but failing to detect differences in certain posttranslational modifications (PTMs), such as phosphorylation pattern changes of alpha-endosulfine. This work illustrates the potency of a combined bottom-up and top-down proteomics approach to deepen our knowledge of cancer biology, especially when genomic data are available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/mcp.m114.047480

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 85

Metadata

Authors
Ntai, I., LeDuc, R. D., Fellers, R. T., Erdmann-Gilmore, P., Davies, S. R., Rumsey, J., Early, B. P., Thomas, P. M., Li, S., Compton, P. D., Ellis, M. J. C., Ruggles, K. V., Fenyö, D., Boja, E. S., Rodriguez, H., Townsend, R. R., & Kelleher, N. L.
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2016-01
Volume
15
Issue
1
Pages
45-56
ISSN
1535-9476 (ISSN-L)
OpenAlex
W2179083672
Cited by
85
References
7
FWCI
4.53
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts. https://app.cochat.ai/papers/10.1074/mcp.m114.047480
The paper
Ntai, I., LeDuc, R. D., Fellers, R. T., Erdmann-Gilmore, P., Davies, S. R., Rumsey, J., Early, B. P., Thomas, P. M., Li, S., Compton, P. D., Ellis, M. J. C., Ruggles, K. V., Fenyö, D., Boja, E. S., Rodriguez, H., Townsend, R. R., & Kelleher, N. L. (2016). Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts. Molecular & Cellular Proteomics. https://doi.org/10.1074/mcp.m114.047480

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.